Venatorx Pharmaceuticals, based in Malvern, Pennsylvania, is a clinical-stage biopharmaceutical company focused on developing novel anti-infectives to treat multi-drug-resistant (MDR) bacterial and hard-to-treat viral infections. The company conducts clinical trials across North America and internationally, including studies involving participants in multiple EU Member States.
To meet its legal obligations and strengthen its data protection practices in relation to EU-based trial participants, Venatorx engaged The DPO Centre to act as its EU Representative and provide expert GDPR support.
The DPO Centre began by conducting a high-level compliance review and data mapping exercise to assess Venatorx’s readiness under the GDPR. This included reviewing existing processes and procedures, assessing privacy and consent notices, and identifying relevant data processors. The DPO Centre also supported the drafting of Venatorx’s Records of Processing Activities (RoPA), as required under Article 30 of the GDPR.
To further strengthen internal understanding, The DPO Centre delivered virtual GDPR training tailored to the needs of a US-based pharmaceutical organisation, ensuring staff understad their responsibilities when handling patient data within the context of EU clinical trials.
Heather Hunter, Vice President, Communications, Venatorx Pharmaceuticals said:
‘Venatorx is very pleased with the guidance and support that The DPO Centre has provided us to ensure that we meet the legal requirements of the GDPR.
‘Following the initial data mapping and construction of our RoPA in 2018, we have a good understanding of our processing activities and practical application of the legislation. The DPO Centre recently provided bespoke annual GDPR staff training as part of Venatorx’s ongoing commitment to accountability and compliance. We are confident in the knowledge that our staff understand their responsibilities and The DPO Centre’s team is on hand to assist when required.’
Fill in your details below and we’ll get back to you as soon as possible